Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change

Clinical Immunology and Immunopathology

Volumn 61, Issue 2 PART 1, 1991, Pages 212-224

  Hofmann, Bo ^a,b   Nishanian, Parunag ^a,b   Fahey, John L ^a,b   Esmail, Imu ^a,b   Jackson, Anne L ^b,c   Detels, Roger ^a,b   Cumberland, William ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BD Technologies   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; NEOPTERIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM;

CD4-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN; LYMPHOCYTES; MALE; RECEPTORS, INTERLEUKIN-2; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025938391     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-1229(05)80025-X     Document Type: Article

References (35)

1. Demonstration of a non-Tac peptide that binds interleukin 2
2. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins
3. Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells
4. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells
5. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro
6. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro
7. Identification and characterization of a released form of the interleukin-2 receptor
8. Soluble IL-2 receptor in rheumatoid athritis Correlation with disease activity IL-2 and IL-2 inhibition
9. Correlation of T and B cell activities in vitro and serum IL-2R levels in systemic lupus erythematosus
10. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphatic leukemia
11. Expression of a soluble form of the interleukin-2 receptor in normal and neoplastic states. The human interleukin-2 receptor: Normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic viruses. W. C. Green. moderator
12. In vitro activation of T lymphocytes from HIV-seropositive blood donors. I. Soluble interleukin-2 rector (IL2R) production parallels cellular IL2R expression and DNA synthesis
13. Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV
14. Infection with the human immunodeficiency virus (HIV) is associated with an in vitro increase in B lymphocyte activation and immaturity
15. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection
16. The HIV-induced immunodeficiency: Relatively preserved PHA as opposed to decreased PWM responses may be due to possibly preserved responses via CD2/PHA pathway
17. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS-related symptoms in homosexual mem with HIV antibodies
18. Quantitative analysis of immune function in patients with the acquired immunodeficiency syndrome
19. Immunological studies in AIDS, functional studies of lymphocyte subpopulations
20. Serum neopterin changes in HIV infected subjects: Indicator of significant pathology, CD4 T cell changes, and the development of AIDS
21. Immune activation by HIV: Seroconversion and progression are associated with increases in serum beta-2-microglobulin level
22. Immunological studies of homosexual men, with immunodeficiency and Kaposi's sarcoma
23. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
24. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations
25. Soluble IL-2 receptor in AIDS: Correlation of its serum level with the classification of HIV-induced diseases and its characterization
26. Factors contributing to HTLV-III/LAV infection and T cell immune deficiency and AIDS in a high-risk population
27. Risk factors for seroconversion to human immuno-deficiency virus (HIV) among homosexual men
28. The multicenter AIDS cohort study: Rationale, organization, and selected characteristics of the participants
29. Regression models and life tables
30. HIV-1, HTLV-1 and normal T-cell growth: Transcriptional strategies and surprises
31. Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes
32. Influence of schedule of interleukin 2 admission on therapy with interleukin 2 and lymphokine activated killer cells
33. Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma
34. Investigation of immunosuppressive properties of inactivated human immunodeficiency virus and possible neutralization of this effect by some patient sera
35. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism